Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

QuantumRD Services in China

1 Oct 2012 07:00

RNS Number : 5302N
ViaLogy PLC
01 October 2012
 



ViaLogy to Offer QuantumRD Services in China

 

 

London, UK October 1, 2012. ViaLogy PLC(LSE/AIM: VIY) announces that the company is in exploratory discussions with some of the largest Chinese national oil companies (NOCs) and upstream services providers to deploy QuantumRD® software platform for both their national and global assets.

 

As the world's 4th largest producer, China possesses substantial energy resources that include over 20 billion barrels of oil (14th largest in the world) and 100Tcf of natural gas. China's increasing energy needs coupled with growing emphasis on new discoveries, optimizing primary recovery efficiencies, and cost-effective development of proven fields provide a major opportunity for leveraging QuantumRD capabilities.

 

Some of the key strategic initiatives for Chinese operators include increasing production from mature fields; exploring new offshore areas of Bohai Bay and the South China Sea as well as onshore oil in western interior provinces such as Xinjiang and Inner Mongolia. QuantumRD processing to discover and characterize thin laminates, and delineate reservoirs below seismic resolution in complex tectonic stratigraphy using existing 3-D are seen as particularly attractive to support ongoing programs.

 

ViaLogy is discussing service delivery arrangements whereby QuantumRDsoftware platform can be utilized to determine the locations of new hydrocarbon assets on active fields. QuantumRD®can potentially provide more accurate structural and stratigraphic interpretations of seismic data than is now achievable with industry-standard tools. ViaLogy's software platform broadens the useable seismic spectra for both low and high frequencies, thus extracting porosity, lithology and fluid information from weak signal data normally discarded because it is buried in background noise and is unrecoverable. The technique is a major departure from current industry capabilities in reservoir characterization, and holds the promise of major cost avoidance and discovery of reserves otherwise undetected to increase the success rate of exploratory drilling and hydrocarbon recovery.

 

These business discussions follow issuance of a patent in China for QRI® related technology, which provides the fundamental weak signal processing and computational engine (employing quantum resonance interferometry) for ViaLogy's QuantumRD software platform. The company currently has a number of QuantumRD related patents pending in China.

ViaLogy CEO Robert Dean said, "We are excited by the possibility of applying QuantumRD technology on Chinese prospects, by the business value we could bring to their ongoing exploration and development efforts, and extending their de-risking toolkit for a wide range of conventional and non-conventional formations. We hope to provide the same increases in seismic resolution that we have shown to date with carbonate and sandstone reservoirs in the US and our offshore work in Asia."

Dean added, "We are currently in discussions with potential partners to find the best working structures and business models."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD® platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGUBABUPPGMU
Date   Source Headline
5th Nov 20207:00 amRNSDirectorate Change
3rd Nov 20207:00 amRNSPartnership with Take2 Health Limited
26th Oct 20207:00 amRNSHalf-year Trading update
23rd Oct 20207:00 amRNSCQC accreditation
21st Oct 20207:00 amRNSYourgene Genomic Services collaboration with Cytox
12th Oct 20207:00 amRNSElucigene DPYD tests to be used routinely in Wales
8th Oct 20207:00 amRNSStrategic reproductive health partnership in Japan
7th Oct 20207:00 amRNSIONA®Nx awarded contract with St George’s Hospital
5th Oct 20207:00 amRNSShare Incentive Plan
1st Oct 20204:59 pmRNSCorrection: Holding(s) in Company
1st Oct 20203:29 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSLaunch of Yourgene Genomic Services
25th Sep 20205:28 pmRNSIssue of Share Options
24th Sep 202010:00 amRNSDPD reimbursement in Germany
24th Sep 20207:00 amRNSDirector/PDMR Shareholding
23rd Sep 20205:20 pmRNSExercise of Options
23rd Sep 202012:25 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:14 pmRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Statement
21st Sep 20207:00 amRNSUS distribution agreement for DPYD &other products
9th Sep 20207:00 amRNSAGM update and investor presentation
3rd Sep 20207:00 amRNSIONA® Nx Launch
28th Aug 20207:00 amRNSNotice of AGM & Annual Report 2020
13th Aug 20207:00 amRNSTGA approves IONA® Nx for sale in Australia
11th Aug 20207:00 amRNSAdmission of Company Considerations Shares and TVR
7th Aug 20203:42 pmRNSHolding(s) in Company
7th Aug 20203:25 pmRNSHolding(s) in Company
7th Aug 20209:48 amRNSHolding(s) in Company
5th Aug 20201:15 pmRNSResult of Placing
5th Aug 20207:00 amRNS£16.15m Placing & Close of Accelerated Bookbuild
4th Aug 20205:13 pmRNSProposed Acquisition and Placing
3rd Aug 20207:00 amRNSCE-IVD Mark for Clarigene™ SARS-CoV-2 test
29th Jul 202012:05 pmRNSAppointment of Joint Broker
28th Jul 20207:00 amRNSFinal Results
13th Jul 20201:13 pmRNSNotice of Results
30th Jun 20207:00 amRNSCOVID-19 assay launched
19th Jun 20204:44 pmRNSIssue of Share Options
16th Jun 20207:00 amRNSCollaboration in COVID-19 testing
15th Jun 20207:00 amRNSCE-IVD mark received for Illumina-based IONA® test
26th May 202012:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSCOVID-19 testing service launch; business update
20th May 20207:00 amRNSExercise of Warrants and Options
20th Apr 20207:00 amRNSYear-end Trading update: Revenues increase 86%
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.